JAMA Cardiology

Both and provided independent, clinically important information for predicting risk, supporting joint assessment of cholesterol content and particle number in risk evaluation.

Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease This cohort study reports on whether non–high-density-lipoprotein levels provide information on risk of atherosclerotic cardiovascular disease beyond apolipoprotein B values and vice versa.

Among adults with Friedreich ataxia , intravenous AAVrh.10hFXN gene therapy was well tolerated and associated with increased frataxin, reduced left ventricular mass index, and lower serum troponin I.

https://ja.ma/4y1VlSt